Literature DB >> 18492933

AJR teaching file: incidental hepatic mass.

Sean D Beaty1, Alvin C Silva, Giovanni Depetris.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18492933     DOI: 10.2214/AJR.07.7075

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  6 in total

1.  Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

Authors:  Massimo Galia; Adele Taibbi; Daniele Marin; Alessandro Furlan; Marco Dioguardi Burgio; Francesco Agnello; Giuseppe Cabibbo; Bernard E Van Beers; Tommaso Vincenzo Bartolotta; Massimo Midiri; Roberto Lagalla; Giuseppe Brancatelli
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

Review 2.  Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management.

Authors:  Aikaterini Mastoraki; Maria Ioanna Stefanou; Evangelos Chatzoglou; Nikolaos Danias; Maria Kyriazi; Nikolaos Arkadopoulos; Vasilios Smyrniotis
Journal:  Indian J Hematol Blood Transfus       Date:  2013-05-15       Impact factor: 0.900

Review 3.  Post-operative imaging in liver transplantation: state-of-the-art and future perspectives.

Authors:  Rossano Girometti; Giuseppe Como; Massimo Bazzocchi; Chiara Zuiani
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  MRI of Focal Liver Lesions.

Authors:  Nils Albiin
Journal:  Curr Med Imaging Rev       Date:  2012-05

5.  Magnetic resonance imaging findings in primary lymphoma of the liver: a case report.

Authors:  Fatmir Bilaj; Leart Berdica; Arben Dhima; Gjergji Vreto
Journal:  J Med Case Rep       Date:  2012-09-05

6.  Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist?

Authors:  Francesco Mungai; Mario Morone; Alberta Villanacci; Maria Pia Bondioni; Lorenzo Nicola Mazzoni; Luigi Grazioli; Stefano Colagrande
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.